http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5661314-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 1979-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1daed8ec77c8ae46544b7cbbcd9a3cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08497ca9784bf79a1346313272b4eb7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d261ece80a33fcc60bb459e2f26634f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_207c4342c1224c4b77573623f568445a
publicationDate 1981-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5661314-A
titleOfInvention Preventive against side-effect for dialytic patient
abstract PURPOSE: A preventive for a dialytic patient against side effects, e.g., disorder of blood vessel of heart, weaking of the whole body, etc., comprising carnitine or its salt. n CONSTITUTION: A preventive comprising a dl-, d-, or l-derivative of carnitine shown by the formula or their pharmaceutically acceptable salts as an active ingredient. When a patient of renopathy, etc. is subjected to dialysis continuously, harmful actions such as disorder of blood vessel of heart, e.g, arrhythmia, myocardial infraction, etc., weakening of the whole body, giddiness, headache, etc. occur. But the administration of carmitine is capable of preventing and remedying these harmful actions. The preventive is prescribed orally or parenterally. The reason is uncertain, but the fact that carnitine or its salt reduces a concentration of fatty acid in the blood and has actions to promote the absorption of long-chain Acyl- CoA to mitochondria membtane and to improve the energy metabolism of cardiac muscle is considered to be related to the reason. n COPYRIGHT: (C)1981,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S60156613-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2230953-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2230953-A
priorityDate 1979-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590119
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10917

Total number of triples: 23.